The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Platform study of circulating tumor DNA–directed adjuvant chemotherapy in colon cancer (CLAUDIA Colon Cancer, KCSG CO22-12).
 
Yongjun Cha
Honoraria - Boryung Pharmaceuticals; IMBdx; inno.N; Merck; Ono Pharmaceutical; Takeda
Consulting or Advisory Role - CellabMED, Inc.; IMBdx; IMBdx
 
Jin Won Kim
Consulting or Advisory Role - AstraZeneca; BeiGene Beijing; BeiGene Beijing; BeyondBIO; Bristol-Myers Squibb/Celgene; Eisai; GC Cell; MSD; Ono Pharmaceutical; Roche; Sanofi; Servier; TCUBEit
Research Funding - Boryung Pharmaceuticals; Samyang
 
Taekeun Park
No Relationships to Disclose
 
Sang-Hee Cho
No Relationships to Disclose
 
Moon Ki Choi
No Relationships to Disclose
 
In Gyu Hwang
No Relationships to Disclose
 
Seung-Hoon Beom
No Relationships to Disclose
 
Byung Woog Kang
No Relationships to Disclose
 
Jin-Soo Kim
No Relationships to Disclose
 
Sun Young Kim
Honoraria - Boryung; LG Chem; Merck
Consulting or Advisory Role - AstraZeneca; Guardant Health; Merck; Natera; Roche
Research Funding - Roche/Genentech (Inst)
Expert Testimony - Guardant Health
 
Seung Kim
No Relationships to Disclose
 
Seok Yun Kang
No Relationships to Disclose
 
Sae-Won Han
Honoraria - IMBdx
Consulting or Advisory Role - AstraZeneca; Natera
Research Funding - Abbvie (Inst); Arcus Biosciences (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); BeyondBio (Inst); Cell Biotech (Inst); GC Pharma (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Hanmi (Inst); Hengrui Pharmaceutical (Inst); IMBdx (Inst); Janssen (Inst); Jeil Pharmaceutical Co (Inst); Lilly (Inst); Loxo (Inst); MedImmune (Inst); Mirati Therapeutics (Inst); MSD (Inst); Roche (Inst); Seagen (Inst); Turnstone Bio (Inst)
 
Korea Cancer Study Group
No Relationships to Disclose